![Michael Meluzio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Meluzio
Comptroller/Controller/Auditor at
CUE BIOPHARMA, INC.
Net worth: 1 M $ as of 31/08/2026
Profile
Mr. Michael Meluzio, CPA, is a Chief Accounting Officer & Vice President at Cue Biopharma, Inc. Mr. Meluzio was previously employed as a Chief Financial & Accounting Officer by Kiora Pharmaceuticals, Inc. He received his undergraduate degree from Adelphi University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0.67% | 13/08/2026 | 48,961 ( 0.67% ) | 1 M $ | 31/08/2026 |
Michael Meluzio active positions
| Companies | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01/06/2026 |
Former positions of Michael Meluzio
| Companies | Position | End |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director of Finance/CFO | 18/03/2022 |
Training of Michael Meluzio
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Michael Meluzio
